NoriyasuU, TakayukiF, MasashiK, TetsuoT, ToshihikoY, ShoichiM, KoheiY, YoshitsuguH, KaoruS, YoshitakaS, and ToyoakiH: Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients. Cancer Sci, 2006; 97:387–394.
2.
LorenziPL, ReinholdWC, VarmaS, HutchinsonAA, PommierY, ChanockSJ, and WeinsteinJN: DNA fingerprinting of the NCI-60 cell line panel. Mol Cancer Ther, 2009; 8:713–724.
3.
MiyanagaA, MasudaM, TsutaK, KawasakiK, NakamuraY, SakumaT, AsamuraH, GemmaA, and YamadaT: Hippo pathway gene mutations in malignant mesothelioma revealed by RNA and targeted exon sequencing. J Thorac Oncol, 2015; 10:844–851.
4.
MizutaniN, AbeM, MatsuokaS, KajinoK, WakiyaM, OhtsujiN, HatanoR, MorimotoC, and HinoO: Establishment of anti-mesothelioma monoclonal antibodies. BMC Res Notes, 2016; 9:324.
